Embecta announced today that it discontinued its insulin patch pump program and plans to initiate a restructuring plan.

Medtronic announced today that it received FDA clearance for its new InPen insulin delivery system application.

Abbott modified its original FreeStyle Libre 2 for the purpose of integration with automated insulin delivery systems. It ...

R3 Vascular announced today that the FDA granted investigational device exemption (IDE) to evaluate its Magnitude drug-eluting bioresorbable scaffold. Mountain View, California-based R3 Vascular ...

Abbott announced today that it officially opened a new state-of-the-art manufacturing facility in Kilkenny, Ireland.

Dexcom announced today that it entered into a strategic partnership with Oura, maker of leading smart ring technology.

Medtronic (NYSE:MDT) has plans to submit its MiniMed 780G for an expanded indication from the FDA for type 2 diabetes in the near future.